Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.84M Buy
23,216
+3,615
+18% +$283K 0.43% 37
2020
Q2
$1.45M Buy
19,601
+270
+1% +$20.3K 0.38% 42
2020
Q1
$1.42M Buy
19,331
+16,439
+568% +$1.29M 0.4% 42
2019
Q4
$251K Buy
2,892
+7
+0.2% +$575 0.07% 143
2019
Q3
$232K Buy
2,885
+49
+2% +$3.93K 0.07% 142
2019
Q2
$227K Buy
2,836
+51
+2% +$3.9K 0.07% 138
2019
Q1
$221K Sell
2,785
-255
-8% -$19.1K 0.07% 136
2018
Q4
$222K Sell
3,040
-477
-14% -$33.7K 0.08% 123
2018
Q3
$238K Buy
+3,517
New +$224K 0.08% 125
2017
Q4
Sell
-4,139
Closed -$224K 119
2017
Q3
$224K Sell
4,139
-103
-2% -$6.25K 0.08% 115
2017
Q2
$259K Buy
+4,242
New +$258K 0.09% 115
2016
Q4
Sell
-4,049
Closed -$241K 116
2016
Q3
$241K Buy
+4,049
New +$237K 0.07% 101

Other funds holding MRK

FCG Advisors's MRK Position: Q3 2020 in Review

FCG Advisors increased its Merck (MRK) stake by 18% in Q3 2020, buying an estimated $283K and bringing the position to 23,216 shares worth $1.84M. The position accounts for 0.43% of the portfolio, ranked #37.

FCG Advisors first reported a position in MRK in Q3 2016 and has held it in 12 quarters since. 2,558 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

  • FCG Advisors held 23,216 shares of Merck worth $1.84M as of Q3 2020.
  • FCG Advisors bought 3,615 Merck shares in Q3 2020, an estimated $283K.
  • Merck made up 0.43% of FCG Advisors's portfolio in Q3 2020, its #37 holding.
  • FCG Advisors first reported a position in Merck in Q3 2016 and has held it in 12 quarters since.
  • 2,558 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on FCG Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.